Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma

被引：17

作者：

Antonioli, E ^{[1
]}

Nozzoli, C

Gianfaldoni, G

Mannelli, F

Rossi, S

Betti, S

Bernardeschi, P

Fiorentini, G

Bosi, A

机构：

[1] Univ Florence, Dept Haematol, Azienda Osped Careggi, Florence, Italy

[2] Gen Hosp S Giuseppe, Dept Oncol, Florence, Italy

[3] Gen Hosp S Giuseppe, Dept Med, Florence, Italy

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷 / 11期

关键词：

targeted therapies; EGFR inhibitors; angiogenesis inhibitors; gastric cancer; esophageal cancer;

D O I：

10.1093/annonc/mdi357

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1849 / 1850

页数：2

共 5 条

[1] Thalidomide in multiple myeloma: Current status and future prospects [J].

Cavenagh, JD ;

Oakervee, H .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :18-26

[2]

Cavo M, 2004, HAEMATOLOGICA, V89, P826

[3] Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy [J].

Cavo, M ;

Zamagni, E ;

Cellini, C ;

Tosi, P ;

Cangini, D ;

Cini, M ;

Valdrè, L ;

Palareti, G ;

Masini, L ;

Tura, S ;

Baccarani, M .

BLOOD, 2002, 100 (06) :2272-2273

[4] Pulmonary hypertension and thalidomide therapy in multiple myeloma [J].

Hattori, Y ;

Shimoda, M ;

Okamoto, S ;

Satoh, T ;

Kakimoto, T ;

Ikeda, Y .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (06) :885-887

[5] Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma [J].

Younis, TH .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) :191-192

← 1 →